Molecular determinants of clinical outcomes with pembrolizumab versus paclitaxel in a randomized, open-label, phase III trial in patients with gastroesophageal adenocarcinoma
Shitara, K., Özgüroğlu, M., Bang, Y.-J., Di Bartolomeo, M., Mandalà, M., Ryu, M.-H., Caglevic, C., Chung, H.C., Muro, K., Van Cutsem, E., Kobie, J., Cristescu, R., Aurora-Garg, D., Lu, J., Shih, C.-S., Adelberg, D., Cao, Z.A., Fuchs, C.S.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
Access to innovative medicines for metastatic melanoma worldwide: Melanoma World Society and European Association of Dermato-oncology survey in 34 countries
Kandolf Sekulovic, L., Guo, J., Agarwala, S., Hauschild, A., McArthur, G., Cinat, G., Wainstein, A., Caglevic, C., Lorigan, P., Gogas, H., Alvarez, M., Duncombe, R., Lebbe, C., Peris, K., Rutkowski, P., Stratigos, A., Forsea, A.-M., De La Cruz Merino, L., Kukushkina, M., Dummer, R., Hoeller, C., Gorry, C., Bastholt, L., Herceg, D., Neyns, B., Vieira, R., Arenberger, P., Bylaite-Bucinskiene, M., Babovic, N., Banjin, M., Putnik, K., Todorovic, V., Kirov, K., Ocvirk, J., Zhukavets, A., Ymeri, A., Stojkovski, I., Garbe, C.
Published in European journal of cancer (1990) (01.11.2018)
Published in European journal of cancer (1990) (01.11.2018)
Get full text
Journal Article
Primary and metastatic brain cancer genomics and emerging biomarkers for immunomodulatory cancer treatment
Passiglia, F., Caglevic, C., Giovannetti, E., Pinto, JA, Manca, P., Taverna, S., Listì, A., Gil-Bazo, I., Raez, LE, Russo, A., Rolfo, C.
Published in Seminars in cancer biology (01.10.2018)
Published in Seminars in cancer biology (01.10.2018)
Get full text
Journal Article
Seroconversion and Abundance of IgG Antibodies against S1-RBD of SARS-CoV-2 and Neutralizing Activity in the Chilean Population
González-Stegmaier, R., Cereceda, K., Briones, J. L., Beltran-Pávez, C., Oyarzún-Arrau, A., Riquelme-Barrios, S., Selman, C., Yarad, F., Mahave, M., Caglevic, C., Morales, R., Aguirre, A., Valiente-Echeverría, F., Soto-Rifo, R., Marsiglia, H., Gazitua, R., Villarroel-Espindola, F.
Published in Journal of Immunology Research (2021)
Published in Journal of Immunology Research (2021)
Get full text
Journal Article
KEYNOTE-061: Phase 3 study of pembrolizumab vs paclitaxel for previously treated advanced gastric or gastroesophageal junction (G/GEJ) cancer
Shitara, K., Özgüroğlu, M., Bang, Y J, Di Bartolomeo, M., Mandalà, M., Ryu, M H, Fornaro, L., Olesiński, T., Caglevic, C., Chung, H., Muro, K., Gökkurt, E., Mansoor, W., McDermott, R., Schacham-Shmueli, E., Chen, X., Kang, S P, Mayo, C., Ohtsu, A., Fuchs, C.
Published in Annals of oncology (01.06.2018)
Published in Annals of oncology (01.06.2018)
Get full text
Journal Article
Final analysis of the phase III KEYNOTE-042 study: Pembrolizumab (Pembro) versus platinum-based chemotherapy (Chemo) as first-line therapy for patients (Pts) with PD-L1–positive locally advanced/metastatic NSCLC
Mok, T.S.K, Wu, Y.-L., Kudaba, I., Kowalski, D.M., Cho, B.C., Turna, H.Z., de Castro, G., Srimuninnimit, V., Laktionov, K.K., Bondarenko, I., Kubota, K., Caglevic, C., Karaszewska, B., Dang, T., Yin, L., Penrod, J., Lopes, G.
Published in Annals of oncology (01.04.2019)
Published in Annals of oncology (01.04.2019)
Get full text
Journal Article
PCN145 Clinical Pathways As Input to HTA Processes: Lessons from the Experience of a Referral Cancer Centre
Vera-Rivero, M., Cardenas, Ravena J, Paredes, I., Caglevic, C., Quirland, C.
Published in Value in health (01.06.2021)
Published in Value in health (01.06.2021)
Get full text
Journal Article
P25 Preliminary Experience With the Use of Osimertinib in Chilean Patients
Burotto, M., Samtani, S., Aren, O., Rios, C., Rojas, C., Orlandi, F., Caglevic, C., Vogel, C.
Published in Journal of thoracic oncology (01.09.2018)
Published in Journal of thoracic oncology (01.09.2018)
Get full text
Journal Article
KEYNOTE-033: Phase 3 study of pembrolizumab versus docetaxel in patients with previously treated non–small-cell lung cancer (NSCLC)
Zhou, C., Caglevic, C., Zhou, J., Wang, B., Wang, K., Ge, J., Zhou, Y., Piperdi, B., Ma, Z.
Published in Annals of oncology (01.11.2017)
Published in Annals of oncology (01.11.2017)
Get full text
Journal Article
FP13.04 KEYNOTE-042 3-Year Survival Update: 1L Pembrolizumab vs Platinum-Based Chemotherapy for PD-L1+ Locally Advanced/Metastatic NSCLC
Cho, B.C., Wu, Y., Lopes, G., Kudaba, I., Kowalski, D.M., Turna, H.Z., De Castro, G., Caglevic, C., Zhang, L., Karaszewska, B., Laktionov, K.K., Srimuninnimit, V., Bondarenko, I., Kubota, K., Yin, L., Lin, J., Souza, F., Mok, T.S.K.
Published in Journal of thoracic oncology (01.03.2021)
Published in Journal of thoracic oncology (01.03.2021)
Get full text
Journal Article
1459P Albumin as a simple criterion to reduce early mortality (EM) in gastric cancer (GC) trials
Ozguroglu, M., Shitara, K., Lee, K-W., Fuchs, C.S., Chung, H.C., Di Bartolomeo, M., Chao, J., Wainberg, Z.A., Caglevic, C., Kudaba, I., Van Custem, E., Garrido, M., Lee, J., Ma, J., Cao, Z.A., Shah, S., Shih, C-S., Bhagia, P., Wyrwicz, L., Tabernero, J.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
O-12 KEYNOTE-061: Response to subsequent therapy following second-line pembrolizumab or paclitaxel in patients with advanced gastric or gastroesophageal junction adenocarcinoma
Yoon, H., Fuchs, C., Özgüroğlu, M., Bang, Y., Bartolomeo, M. Di, Mandala, M., Ryu, M., Fornaro, L., Olesinski, T., Caglevic, C., Chung, H., Muro, K., Cutsem, E. Van, Elme, A., Thuss-Patience, P., Chau, I., Ohtsu, A., Wang, A., Bhagia, P., Lin, J., Shih, C., Shitara, K.
Published in Annals of oncology (01.07.2020)
Published in Annals of oncology (01.07.2020)
Get full text
Journal Article
P21.13 Durvalumab in Locally-Advanced NSCLC in LATAM: Real World Data from Patients Included in the Early Access Program
Tsou, F., Angel, M., Reinhold, F., Gabay, C., Bonet, M., Bluthgen, M.V., Minatta, J., Bustos, B., Novas, C., Rizzo, M., Kowalyszyn, R., Cundom, J., Richardet, E., Ferreira, G., Bradley, D. Gomez, Roa, G., Tatangelo, M., Caglevic, C., Pini, A., Paskevicius, M., Flores, M., Pupareli, C., Martin, C.
Published in Journal of thoracic oncology (01.03.2021)
Published in Journal of thoracic oncology (01.03.2021)
Get full text
Journal Article
102OFinal analysis of the phase III KEYNOTE-042 study: Pembrolizumab (Pembro) versus platinum-based chemotherapy (Chemo) as first-line therapy for patients (Pts) with PD-L1–positive locally advanced/metastatic NSCLC
Mok, T S K, Wu, Y-L, Kudaba, I, Kowalski, D M, Cho, B C, Turna, H Z, de Castro, G, Srimuninnimit, V, Laktionov, K K, Bondarenko, I, Kubota, K, Caglevic, C, Karaszewska, B, Dang, T, Yin, L, Penrod, J, Lopes, G
Published in Annals of oncology (01.04.2019)
Published in Annals of oncology (01.04.2019)
Get full text
Journal Article
21O Coformulated vibostolimab/pembrolizumab in advanced cervical cancer: KEYVIBE-005
Leary, A., Yonemori, K., Le Tourneau, C., Lugowska, I., Tosi, D., Ghiringhelli, F., Ozyilkan, O., Caglevic, C., Ruiz, E.P. Yanez, Rha, S.Y., van Dongen, M.G., Perets, R., Shapira-Frommer, R., Doi, T., Chou, H-H., Cicin, I., Liu, Q., Keenan, T., Healy, J., Rojas, C.I.
Published in ESMO open (01.06.2024)
Published in ESMO open (01.06.2024)
Get full text
Journal Article
22O Association of biomarkers with response to coformulated vibostolimab/pembrolizumab (vibo/pembro) in metastatic cervical cancer (CC): Exploratory analysis from the phase II KEYVIBE-005 study
Le Tourneau, C., Rojas, C.I., Leary, A., Yonemori, K., Lugowska, I., Tosi, D., Ghiringhelli, F., Caglevic, C., Ruiz, E.P. Yanez, Perets, R., Rha, S.Y., Salman, P., Doi, T., Zhang, Y., Akturk, G., Pena, C.E., Keenan, T., Chen, Y., Dettman, E., Ozyilkan, O.
Published in ESMO open (01.06.2024)
Published in ESMO open (01.06.2024)
Get full text
Journal Article
25P Patient-reported outcomes (PROs) with coformulated vibostolimab/pembrolizumab (vibo/pembro) for metastatic cervical cancer (CC): Results from the KEYVIBE-005 study
Yonemori, K., Rojas, C.I., Leary, A., Le Tourneau, C., Lugowska, I., Ozyilkan, O., Caglevic, C., Ghiringhelli, F., Ruiz, E.P. Yanez, Dongen, M.V., Perets, R., Gumus, M., Kwiatkowski, M., Rha, S.Y., Salman, P., Liu, Q., Keenan, T., Nguyen, A.M., Singhal, P., Tosi, D.
Published in ESMO open (01.06.2024)
Published in ESMO open (01.06.2024)
Get full text
Journal Article
LBA-005KEYNOTE-061: Phase 3 study of pembrolizumab vs paclitaxel for previously treated advanced gastric or gastroesophageal junction (G/GEJ) cancer
Shitara, K, Özgüroğlu, M, Bang, Y J, Di Bartolomeo, M, Mandalà, M, Ryu, M H, Fornaro, L, Olesiński, T, Caglevic, C, Chung, H, Muro, K, Gökkurt, E, Mansoor, W, McDermott, R, Schacham-Shmueli, E, Chen, X, Kang, S P, Mayo, C, Ohtsu, A, Fuchs, C
Published in Annals of oncology (01.06.2018)
Published in Annals of oncology (01.06.2018)
Get full text
Journal Article
Abstract P5-18-21: A Phase II randomized trial of lapatinib with either vinorelbine or capecitabine as first- and second-line therapy for ErbB2-overexpressing metastatic breast cancer (MBC)
Janni, W, Sarosiek, T, Pikiel, J, Karaszewska, B, Staroslawska, E, Salat, C, Caglevic, C, Potemski, P, Brain, E, Briggs, K, de Silvio, M, Sapunar, F, Papadimitriou, C
Published in Cancer research (Chicago, Ill.) (15.12.2012)
Published in Cancer research (Chicago, Ill.) (15.12.2012)
Get full text
Journal Article
Serological Profile Of Specific Antibodies Against Dominant Antigens Of SARS-CoV-2 In Chilean COVID-19 Patients
Cereceda, K, González-Stegmaier, R, Briones, Jl, Selman, C, Aguirre, A, Valenzuela-Nieto, G, Caglevic, C, Gazitua, R, Rojas-Fernandez, A, Villarroel-Espíndola, F
Published in bioRxiv (05.02.2021)
Published in bioRxiv (05.02.2021)
Get full text
Paper